Company profile: Windgap Medical
1.1 - Company Overview
Company description
- Provider of drug delivery medical devices for severe allergies and other therapeutic areas, including ANDIPen, a wet/dry dual-chamber autoinjector with improved temperature resilience and extended shelf life, and LVDC for large-volume dual-chamber injections of high-viscosity or difficult-to-mix medications with IM and SubQ options. Develops platforms to stabilize heat- and time-sensitive liquids and collaborates with pharmaceutical partners to commercialize its technology.
Products and services
- Drug Delivery Platforms: WindGap Medical engineers modular devices that stabilize heat- and time-sensitive liquids, enhancing reliable delivery of temperature-sensitive therapeutics
- ANDIPen: A custom-engineered wet/dry dual-chamber autoinjector that improves temperature resilience and extends shelf life for severe allergies
- LVDC: A clinical-grade large-volume dual-chamber injection device that handles high-viscosity or difficult-to-mix medications, with selectable needle lengths for intramuscular or subcutaneous administration
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Windgap Medical
Hallux
HQ: United States
Website
- Description: Provider of a physician-applied topical terbinafine gel for treating onychomycosis. Hallux Subungual Gel (HSG) is applied directly onto the nail bed, utilizing the subungual space for targeted delivery to the infection site.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hallux company profile →
Bioject
HQ: United States
Website
- Description: Provider of needle-free injection therapies to improve administration of liquid medications, including pharmaceuticals, vaccines, and biologics, using technology that forces medication at high speed through a tiny orifice held against the skin, with over 25 years of experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioject company profile →
Elucida Oncology
HQ: United States
Website
- Description: Provider of targeted C'Dot Drug Conjugates (CDCs) for patients with primary solid tumor and metastatic cancer. Ultra-small CDC nanoparticles penetrate tumors, carry high drug payloads, and clear rapidly via kidneys (Target or Clear) to reduce systemic exposure and off-target toxicity. Pipeline includes ELU001, a CDC targeting folate receptor alpha in clinical trials; ELU002; and surface chemistry for toxic payloads and radionuclides.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elucida Oncology company profile →
CeQur
HQ: Switzerland
Website
- Description: Provider of wearable insulin delivery solutions for people with diabetes, including the CeQur Simplicity insulin patch that delivers mealtime bolus insulin via a small, flexible cannula without injections. Offers a Patient Starter Kit with patches and a reusable inserter, the CeQur Cares support program, and the CeQur Simplicity Copay Savings Card. Works with physicians and centers to bring technology to patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CeQur company profile →
Acorda Therapeutics
HQ: United States
Website
- Description: Provider of commercial-stage biopharmaceutical therapies, identifying, developing and commercializing therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other nervous system disorders. Products include INBRIJA (levodopa inhalation powder for Parkinson’s symptoms), AMPYRA (dalfampridine to improve walking in adults with MS), and the ARCUS drug delivery platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acorda Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Windgap Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Windgap Medical
2.2 - Growth funds investing in similar companies to Windgap Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Windgap Medical
4.2 - Public trading comparable groups for Windgap Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →